Revvity gains FDA clearance for IDS' Total Testosterone assay, expanding its automated endocrine testing platform for ...

Revvity has received FDA clearance for its total testosterone automated ChLIA via its Immunodiagnostic Systems subsidiary.

The company said the test can measure total testosterone, free testosterone, and sex hormone-binding globulin with an integrated workflow on a single platform.

Revvity, Inc., through its subsidiary, Immunodiagnostic Systems (IDS), today announced that it received clearance from the ...

Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices ...

A novel AI-assisted biosensor for choline quantification in milk combines chemiluminescence and smartphone technology, ...

UCLA researchers have introduced a portable, AI-enhanced sensor that can detect three critical cardiac biomarkers in under 25 minutes with accuracy comparable to laboratory analyzers. The dual-mode ...

False-positive HIV-2 serology poses a diagnostic challenge, particularly in chronic infectious or inflammatory diseases that induce polyclonal B cell activation. Leprosy, caused by Mycobacterium ...

New ELISA sphingotest® penKid® enables widespread measurement of the kidney function biomarker Proenkephalin 119-159 (penKid) using standard laboratory equipment.Only available test to match ...

CAMBRIDGE, England, April 13, 2026 /PRNewswire/ -- Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, today announced SimpleStep Ignite™ ELISA, a next ...